1380244-47-2

Upstream product

• 2186-92-7 p-Anisaldehyde dimethyl acetal 
• 1380244-46-1 (S)-2-((2S,4S,5R,6S)-6-ethyl-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl)propan-1-ol 
• 1380244-45-0 (S)-4-benzyl-3-((R)-2-((2S,4R,5R,6S)-6-ethyl-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl)propanoyl)oxazolidin-2-one 

Downstream Products

• 1380244-53-0 (2R,4R,6S,7S,8S,9S)-2-((2S,4R,5R,6S)-6-ethyl-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl)-9-((4-methoxybenzyl)oxy)-4,6,8,10-tetramethyl-7-((triethylsilyl)oxy)undecane-3,5-dione 

Relevant academic research and scientific papers

In silico inspired total synthesis of (-)-dolabriferol

Going retro: The diazabicycloundecane-induced retro-Claisen rearrangement of a linear precursor serves as the key step to form the hindered ester of the polypropionate dolabriferol (1, see scheme, PMB=p-methoxybenzyl, PMP=p-methoxyphenyl, TES=triethylsilyl). The rearrangement is thought to mimic the biosynthetic formation of 1. Copyright